# FDA Inspection 1012395 - ImpactLife - April 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/impactlife/5f9f44ba-adf9-4e9d-ba40-296d8993ed09
Source feed: FDA_Inspections

> FDA Inspection 1012395 for ImpactLife on April 21, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1012395
- Company Name: ImpactLife
- Inspection Date: 2017-04-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1282406 - 2025-08-28](https://www.keypedia.com/records/fda_inspections/impactlife/bc3dcac3-5d39-4f2b-878b-dcadc0facc2b)
- [FDA Inspection 1282406 - 2025-08-28](https://www.keypedia.com/records/fda_inspections/impactlife/4a32cbba-cb23-4949-bfe5-3e8a4ee88977)
- [FDA Inspection 1196520 - 2023-01-24](https://www.keypedia.com/records/fda_inspections/impactlife/2c4e8dc2-d181-4a2c-b8de-87c22858602e)
- [FDA Inspection 1196520 - 2023-01-24](https://www.keypedia.com/records/fda_inspections/impactlife/d0049fc2-3e1e-46b2-972c-95022998a8b1)
- [FDA Inspection 1101791 - 2019-07-11](https://www.keypedia.com/records/fda_inspections/impactlife/5cd8ef8f-6870-4f23-98a1-02809eb311a0)

Company: https://www.keypedia.com/companies/impactlife/bbad3860-707d-488e-9f8d-5f19bf219ad3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d